Skip to content

2022 July 7 release

Compare
Choose a tag to compare
@brendanreardon brendanreardon released this 07 Jul 17:28
· 27 commits to main since this release
7963296

Added entries:

  • (FDA) BRAF p.V600E and sensitivity to dabrafenib in combination with trametinib in any solid tumor.
  • (FDA) IDH1 p.R132C, p.R132H and sensitivity to ivosidenib either with azacitidine or as a monotherapy in acute myeloid leukemia.
  • (FDA) MSI-H and sensitivity to pembrolizumab in endometrial carcinoma.